These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 33118816)

  • 1. REINVENT 2.0: An AI Tool for De Novo Drug Design.
    Blaschke T; Arús-Pous J; Chen H; Margreitter C; Tyrchan C; Engkvist O; Papadopoulos K; Patronov A
    J Chem Inf Model; 2020 Dec; 60(12):5918-5922. PubMed ID: 33118816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Has Artificial Intelligence Impacted Drug Discovery?
    Patronov A; Papadopoulos K; Engkvist O
    Methods Mol Biol; 2022; 2390():153-176. PubMed ID: 34731468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reinvent 4: Modern AI-driven generative molecule design.
    Loeffler HH; He J; Tibo A; Janet JP; Voronov A; Mervin LH; Engkvist O
    J Cheminform; 2024 Feb; 16(1):20. PubMed ID: 38383444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep Learning Applied to Ligand-Based De Novo Drug Design.
    Palazzesi F; Pozzan A
    Methods Mol Biol; 2022; 2390():273-299. PubMed ID: 34731474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target2DeNovoDrug: a novel programmatic tool for
    Madaj R; Geoffrey B; Sanker A; Valluri PP
    J Biomol Struct Dyn; 2022 Oct; 40(16):7511-7516. PubMed ID: 33703998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Has Drug Design Augmented by Artificial Intelligence Become a Reality?
    Chen H; Engkvist O
    Trends Pharmacol Sci; 2019 Nov; 40(11):806-809. PubMed ID: 31629547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De Novo Molecular Design with Chemical Language Models.
    Grisoni F; Schneider G
    Methods Mol Biol; 2022; 2390():207-232. PubMed ID: 34731471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Icolos: a workflow manager for structure-based post-processing of de novo generated small molecules.
    Moore JH; Bauer MR; Guo J; Patronov A; Engkvist O; Margreitter C
    Bioinformatics; 2022 Oct; 38(21):4951-4952. PubMed ID: 36073898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Based
    Ma B; Terayama K; Matsumoto S; Isaka Y; Sasakura Y; Iwata H; Araki M; Okuno Y
    J Chem Inf Model; 2021 Jul; 61(7):3304-3313. PubMed ID: 34242036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial intelligence in drug discovery: applications and techniques.
    Deng J; Yang Z; Ojima I; Samaras D; Wang F
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34734228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survey of generative AI for de novo drug design: new frontiers in molecule and protein generation.
    Tang X; Dai H; Knight E; Wu F; Li Y; Li T; Gerstein M
    Brief Bioinform; 2024 May; 25(4):. PubMed ID: 39007594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial Intelligence in
    Kumar R; Sharma A; Alexiou A; Ashraf GM
    Curr Top Med Chem; 2022; 22(30):2483-2492. PubMed ID: 36263480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graph neural networks for automated de novo drug design.
    Xiong J; Xiong Z; Chen K; Jiang H; Zheng M
    Drug Discov Today; 2021 Jun; 26(6):1382-1393. PubMed ID: 33609779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial intelligence in drug discovery: recent advances and future perspectives.
    Jiménez-Luna J; Grisoni F; Weskamp N; Schneider G
    Expert Opin Drug Discov; 2021 Sep; 16(9):949-959. PubMed ID: 33779453
    [No Abstract]   [Full Text] [Related]  

  • 15. Structure-Based Drug Discovery with Deep Learning.
    Özçelik R; van Tilborg D; Jiménez-Luna J; Grisoni F
    Chembiochem; 2023 Jul; 24(13):e202200776. PubMed ID: 37014633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DockStream: a docking wrapper to enhance de novo molecular design.
    Guo J; Janet JP; Bauer MR; Nittinger E; Giblin KA; Papadopoulos K; Voronov A; Patronov A; Engkvist O; Margreitter C
    J Cheminform; 2021 Nov; 13(1):89. PubMed ID: 34789335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial intelligence in drug design.
    Zhong F; Xing J; Li X; Liu X; Fu Z; Xiong Z; Lu D; Wu X; Zhao J; Tan X; Li F; Luo X; Li Z; Chen K; Zheng M; Jiang H
    Sci China Life Sci; 2018 Oct; 61(10):1191-1204. PubMed ID: 30054833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De Novo Molecule Design by Translating from Reduced Graphs to SMILES.
    Pogány P; Arad N; Genway S; Pickett SD
    J Chem Inf Model; 2019 Mar; 59(3):1136-1146. PubMed ID: 30525594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DrugGen: a database of de novo-generated molecular binders for specified target proteins.
    Qian H; Zhou J; Tu S; Xu L
    Database (Oxford); 2023 Dec; 2023():. PubMed ID: 38150626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generative Models for De Novo Drug Design.
    Tong X; Liu X; Tan X; Li X; Jiang J; Xiong Z; Xu T; Jiang H; Qiao N; Zheng M
    J Med Chem; 2021 Oct; 64(19):14011-14027. PubMed ID: 34533311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.